Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Yuyan Zheng is a leading thoracic surgeon whose research is reshaping the surgical management of non-small-cell lung cancer (NSCLC), with a particular focus on the comparative effectiveness of robotic-assisted lobectomy (RAL) versus video-assisted thoracoscopic lobectomy (VAL). Her major contributions stem from rigorous, high-impact clinical trials that directly address critical gaps in the evidence base. Most notably, she is the principal investigator of the RVlob randomized controlled trial (2024, 19 citations), one of the first prospective studies to demonstrate that RAL and VAL yield comparable long-term survival and perioperative outcomes for resectable NSCLC. This landmark work, alongside her highly cited 2021 study (116 citations) on perioperative outcomes, provides surgeons with crucial data for informed decision-making. Dr. Zheng has also pioneered the assessment of patient-centered outcomes, as evidenced by her 2023 study (25 citations) on health-related quality of life following these procedures. By systematically evaluating both clinical efficacy and patient well-being, her research is helping to define the true value of robotic surgery in thoracic oncology, guiding clinical practice and future innovation.